Resultados de búsqueda - (ligue OR ((migne OR (like OR life)) OR (mignel OR (magne OR (magnatron OR magnoto))))) 1~

  1. 121
  2. 122
  3. 123
  4. 124
  5. 125

    Values, preferences and burden of treatment for the initiation of GLP-1 receptor agonists and SGLT-2 inhibitors in adult patients with type 2 diabetes: a systematic review por González González, José Gerardo, Díaz González Colmenero, Alejandro, Millán Alanís, Juan Manuel, Lytvyn, Lyubov, Solís, Ricardo Cesar, Mustafa, Reem A, Palmer, Suetonia C, Li, Sheyu, Hao, Qiukui, Alvarez Villalobos, Neri Alejandro, Vandvik, Per Olav, Rodríguez Gutiérrez, René

    “…Objectives Assess values, preferences and burden of treatment that patients with type 2 diabetes consider when initiating glucagon-like peptide-1 receptor agonists (GLP-1 RA) or sodium-glucose cotransporter-2 inhibitors (SGLT-2i) compared with other glucose-lowering options.Methods Paired reviewers independently included studies reporting quantitative or qualitative methods to assess values, preferences and burden of treatment reported by patients with type 2 diabetes regarding the initiation of GLP-1 RA or SGLT-2i over other alternatives. …”
    Enlace del recurso
    Artículo
  6. 126
  7. 127
  8. 128
  9. 129
  10. 130
  11. 131
  12. 132
  13. 133
  14. 134
  15. 135
  16. 136
  17. 137
  18. 138
  19. 139
  20. 140

Herramientas de búsqueda: